Risk Factors for Infection Recurrence After Surgical Resection of Advanced Stage Osteonecrosis of the Mandible
- PMID: 38199239
- DOI: 10.1016/j.joms.2024.01.001
Risk Factors for Infection Recurrence After Surgical Resection of Advanced Stage Osteonecrosis of the Mandible
Abstract
Background: Advanced stage osteoradionecrosis (ORN) and medication-related osteonecrosis of the jaw (MRONJ) are challenging disease entities requiring multimodal therapy including surgical resection. However, risk factors associated with infection recurrence are poorly understood.
Purpose: The purpose of this study was to identify risk factors associated with infection recurrence following resection of advanced stage ORN or MRONJ of the mandible.
Study design, setting, sample: This was a retrospective cohort study including patients who underwent segmental mandibulectomy for management of ORN or MRONJ between 2016 and 2021 at the authors' institution. Subjects who did not have margin viability data were excluded.
Predictor/exposure/independent variable: The primary predictor variable was viability of resection margins on histopathologic analysis (viable or nonviable). Secondarily, other risk factors categorized as demographic (age, sex, race), medical (comorbidities), and perioperative (reconstructive modality, antibiotic duration, microbiological growth) were evaluated.
Main outcome variable: The primary outcome variable was time to infection recurrence defined as time from surgical resection to clinical diagnosis of a fistula tract, abscess, or persistent inflammatory symptoms necessitating surgical intervention.
Covariates: Not applicable.
Analyses: Descriptive and bivariate statistics were used to identify associations between risk factors and time to infection recurrence. A significance level of P ≤ .05 was considered significant.
Results: The cohort consisted of 57 subjects with a mean age of 63.3 ± 10.0 years (71.9% Male, 75.4% White) treated for ORN (47.4%) or MRONJ (52.6%). A total of 19/57 (33%) subjects developed a recurrence of infection with 1 and 2 year survival of 75.8 and 66.2%, respectively. Nonviable resection margins were associated with earlier time to infection recurrence (P ≤ .001, hazard ratio (HR) = 11.9, 95% confidence interval (CI) = 3.84 to 36.7) as was younger age (P = .005, HR = 0.921, 95% CI = 0.869 to 0.976) and atypical pathogen growth on culture (P = .002, HR = 8.58, 95% CI = 2.24 to 32.8).
Conclusions and relevance: Histopathologic margin viability was associated with earlier time to infection recurrence following resection of advanced stage ORN or MRONJ of the mandible. Additional studies are needed to identify interventions that may improve outcomes in this demographic.
Copyright © 2024 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Antiresorptive therapy in combination with radiation results in enhanced risk for necrosis and associated complicatifions.Oral Surg Oral Med Oral Pathol Oral Radiol. 2025 Jan;139(1):11-19. doi: 10.1016/j.oooo.2024.07.008. Epub 2024 Aug 9. Oral Surg Oral Med Oral Pathol Oral Radiol. 2025. PMID: 39472248
-
What Affects Healing Rates in Patients Treated for Medication-Related Osteonecrosis of the Jaw? The Role of Operative Therapy and Other Clinical Factors.J Oral Maxillofac Surg. 2024 Nov;82(11):1441-1455. doi: 10.1016/j.joms.2024.06.176. Epub 2024 Jun 29. J Oral Maxillofac Surg. 2024. PMID: 39013476
-
Bone Margin Analysis for Osteonecrosis and Osteomyelitis of the Jaws.Oral Maxillofac Surg Clin North Am. 2017 Aug;29(3):301-313. doi: 10.1016/j.coms.2017.03.007. Oral Maxillofac Surg Clin North Am. 2017. PMID: 28709531 Review.
-
Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw.Oral Maxillofac Surg. 2018 Mar;22(1):59-63. doi: 10.1007/s10006-017-0667-5. Epub 2017 Dec 9. Oral Maxillofac Surg. 2018. PMID: 29224060
-
Comparing the Surgical Response of Bisphosphonate-Related Versus Denosumab-Related Osteonecrosis of the Jaws.J Oral Maxillofac Surg. 2021 May;79(5):1045-1052. doi: 10.1016/j.joms.2020.11.017. Epub 2020 Nov 26. J Oral Maxillofac Surg. 2021. PMID: 33358707 Review.
Cited by
-
Postoperative Recurrence of Medication-Related Osteonecrosis of the Jaw: A Retrospective Study of 150 Patients Undergoing Surgery.Cureus. 2024 Jun 22;16(6):e62930. doi: 10.7759/cureus.62930. eCollection 2024 Jun. Cureus. 2024. PMID: 39044867 Free PMC article.
-
Demineralized Dentin Matrix Incorporated with rhBMP-2 Composite Graft for Treating Medication-Related Osteonecrosis of the Jaw.J Clin Med. 2024 Aug 16;13(16):4830. doi: 10.3390/jcm13164830. J Clin Med. 2024. PMID: 39200972 Free PMC article.
-
Clinical outcome and volumetric 3D analysis of biofluorescence imaging system guided surgery for Medication-Related Osteonecrosis of the Jaw(MRONJ).BMC Oral Health. 2025 Jan 23;25(1):123. doi: 10.1186/s12903-025-05484-7. BMC Oral Health. 2025. PMID: 39849442 Free PMC article.
-
Medication-related osteonecrosis of the jaw: a retrospective single center study of recurrence-related factors after surgical treatment.Clin Oral Investig. 2024 Sep 25;28(10):549. doi: 10.1007/s00784-024-05911-z. Clin Oral Investig. 2024. PMID: 39317736 Free PMC article.
-
Determination of adequate bony resection margins in inflammatory jaw pathologies using SPECT-CT in primary mandibular reconstruction with virtually planned vascularized bone flaps.Clin Oral Investig. 2025 Jan 28;29(1):93. doi: 10.1007/s00784-025-06170-2. Clin Oral Investig. 2025. PMID: 39870950 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical